A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity

Metabolism: Clinical and Experimental

Volumn 61, Issue 5, 2012, Pages 742-753

  Clark, Tod A ^a   Heyliger, Clayton E ^b   Kopilas, Melanie ^c   Edel, Andrea L ^c   Junaid, Asad ^a   Aguilar, Floribeth ^c   Smyth, Donald D ^a   Thliveris, James A ^a   Merchant, Michele ^c   Kim, Hae K ^c   Pierce, Grant N ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Ross University   (Saint Kitts and Nevis)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BLACK TEA DECOCTION; GLUCOSE; INSULIN; UNCLASSIFIED DRUG; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG SAFETY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TOXICITY TESTING;

AMYLASES; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; EATING; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TEA; TRIGLYCERIDES; VANADATES;

EID: 84860243148     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.10.007     Document Type: Article

References (24)

1. C.E. Heyliger, A.G. Tahiliani, and J.H. McNeill Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats Science 227 1985 1474 1477
2. J.L. Domingo Vanadium and diabetes. What about vanadium toxicity? Mol Cell Biochem 203 2000 185 187
3. J.L. Domingo, M. Gomez, J.M. Llobet, J. Corbella, and C.L. Keen Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used Toxicology 66 1991 279 287
4. G. Boden, X. Chen, J. Ruiz, G.D. van Rossum, and S. Turco Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus Metabolism 45 1996 1130 1135
5. A.K. Srivastava Anti-diabetic and toxic effects of vanadium compounds Mol Cell Biochem 206 2000 177 182
6. A.B. Goldfine, M.E. Patti, and L. Zuberi Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies Metabolism 49 2000 400 410
7. A. Shisheva, O. Ikonomov, and Y. Shechter The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats Endocrinology 134 1994 507 510
8. V.G. Yuen, C. Orvig, K.H. Thompson, and J.H. McNeill Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV) Can J Physiol Pharmacol 71 1993 270 276
9. V.G. Yuen, C. Orvig, and J.H. McNeill Effects of bis(maltolato) oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats Am J Physiol 272 1 Pt 1 1997 E30 E35
10. S.K. Pandey, M.B. Anand-Srivastava, and A.K. Srivastava Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation Biochemistry 37 1998 7006 7014
11. C. Orvig, K.H. Thompson, M. Battell, and J.H. McNeill Vanadium compounds as insulin mimics Met Ions Biol Syst 31 1995 575 594
12. A. Peirce The American Pharmaceutical Association practical guide to natural medicines First Edition 1999 Stonesong Press New York
13. T.A. Clark, C.E. Heyliger, A.L. Edel, D.P. Goel, and G.N. Pierce Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats Metabolism 53 2004 1145 1151
14. G.N. Pierce, and N.S. Dhalla Myofibrillar ATPase activities in diabetic myocardium J Mol Cell Cardiol 13 1981 1063 1069
15. G.N. Pierce, M.J.B. Kutryk, and N.S. Dhalla Alterations in calcium binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes Proc Natl Acad Sci U S A 80 1983 5412 5416
16. T.A. Clark, A.L. Edel, C.E. Heyliger, and G.N. Pierce Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound Can J Physiol Pharmacol 82 2004 888 894
17. A.L. Edel, M. Kopilas, and T.A. Clark Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats Metabolism 55 2006 263 270
18. J. Luft Improvements in epoxy resin embedding methods J Biophys Biochem Cytol 9 1961 409 414
19. U.H. Malabu, S. Dryden, H.D. McCarthy, A. Kilpatrick, and G. Williams Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding Diabetes 43 1994 9 15
20. G. Swarup, S. Cohen, and D. Garbers Inhibition of membrane phosphotyrosyl protein phosphatase activity by vanadate Biochem Biophys Res Commun 107 1982 1104 1109
21. N. Rakieten, B.S. Gordon, A. Beaty, D.A. Cooney, P.S. Schein, and R.L. Dixon Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes Proc Soc Exp Biol Med 151 1976 356 361
22. K. Inoue, M. Cetkovic-Cvrlje, D.L. Eizirik, and V. Grill Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats Diabetologia 37 1994 351 357
23. D.M. Smith, R.M. Pickering, and G.T. Lewith A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus Quarterly J Med 101 2008 351 358
24. K.H. Thompson, J. Lichter, C. LeBel, M.C. Scaife, J.H. McNeill, and C. Orvig Vanadium treatment of type 2 diabetes: a view to the future J Inorg Biochem 103 2009 554 558